Childhood asthma outcomes during the COVID-19 pandemic: findings from the PeARL multinational cohort

Accepted/In Press date: 2021

e-pub ahead of print date: 20 February 2021

Published date: June 2021

Additional Information: Funding Information: This study was supported by the Respiratory Effectiveness Group (REG). REG has received support from AstraZeneca, Novartis, and Sanofi for continued work on PeARL. AGM was supported by the National Institute of Health Research Manchester Biomedical Research Centre (NIHR Manchester BRC). We thank Mrs Maria Kritikou for excellent administrative support of the study. Funding Information: This study was supported by the Respiratory Effectiveness Group (REG). REG has received support from AstraZeneca, Novartis, and Sanofi for continued work on PeARL. TJ reports grants from The Paulo Foundation, Helsinki, Finland. MT reports grants from The Sigrid Juselius Foundation, Helsinki, Finland, during the conduct of the study. None of the other authors had any conflicts of interest directly related to this work. AND, AF, KN,EH, LN‐B, WP, ZC, WF, GW, LG‐M, ZAW‐S, YRHV, CFPB, DRY, CS, PLR, PS, RA‐T, J‐CD, JL, TR, DY, AMR, KW, RE‐O, JAC‐R, AG, CM, AILG, MM‐A, EMNR, MKN, VF, and ER‐Z do not declare any conflicts of interest outside the submitted work either. NGP reports personal fees from ALK, Novartis, Nutricia, HAL, Menarini/FAES Farma, Sanofi, Mylan/MEDA, Biomay, AstraZeneca, GSK, MSD, ASIT BIOTECH, and Boehringer Ingelheim; grants from Gerolymatos International SA and Capricare outside the submitted work. AGM reports grants from Boehringer Ingelheim outside the submitted work. AC reports personal fees from Novartis, Thermo Fisher Scientific, Philips, Sanofi, Stallergenes Greer, AstraZeneca, outside the submitted work. AD reports personal fees and other from Novartis, ALK, MYLAN, GSK,CHIESI, Astra Zeneca, DBV technologies, grants and personal fees from Stallergenes Greer, personal fees from AImmune, Zambon, Boehringer Ingelheim, Nestlé HealthScience, other from Nutricia, outside the submitted work. IA reports and Associate Editor Allergy journal. PXreports personal fees from Nutricia, Nestle, Menarini, Uriach, Novartis PharmaAG, and GlaxoSmithkline outside the submitted work. CM reports personal fees from Novartis, GSK, ThermoFisher, Boehringer Ingelheim, outside the submitted work. Publisher Copyright: © 2021 The Authors. Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.

Keywords: childhood asthma, coronavirus, COVID-19

Local EPrints ID: 448495

URI: http://eprints.soton.ac.uk/id/eprint/448495

DOI: doi:10.1111/all.14787

ISSN: 0105-4538

PURE UUID: 7361e7ac-0282-4442-b96e-43541e7ed686

ORCID for Graham C. Roberts: orcid.org/0000-0003-2252-1248

Date deposited: 23 Apr 2021 16:31

Last modified: 18 Mar 2024 03:01